Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Guidelines for the management of mature T‐ and natural killer‐cell lymphomas (excluding cutaneous T‐cell lymphoma): a British Society for Haematology Guideline
Christopher P. Fox, Matthew J. Ahearne, Ruth Pettengell, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 3, pp. 507-522
Open Access | Times Cited: 21

Showing 21 citing articles:

Global patterns of non‐Hodgkin lymphoma in 2020
Allini Mafra da Costa, Mathieu Laversanne, Mary Gospodarowicz, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 9, pp. 1474-1481
Closed Access | Times Cited: 35
Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell Lymphoma
Robert Stuver, Alison J. Moskowitz
Cancers (2023) Vol. 15, Iss. 3, pp. 589-589
Open Access | Times Cited: 16
Current and upcoming treatment approaches to uncommon subtypes of PTCL (EATL/MEITL, SPTCL, HSTCL)
Enrica Marchi, Jeffrey W. Craig, Matko Kalac
Blood (2024) Vol. 144, Iss. 18, pp. 1898-1909
Closed Access | Times Cited: 4
Analysis of anxiety and depression and influencing factors in non-Hodgkin's lymphoma of the nasal cavity and paranasal sinus
Xudong Gao, Jin Zhang, An Li, et al.
World Journal of Psychiatry (2025) Vol. 15, Iss. 4
Closed Access
Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management
Eric Tse, Christopher P. Fox, Alexander Glover, et al.
Seminars in Hematology (2022) Vol. 59, Iss. 4, pp. 198-209
Open Access | Times Cited: 14
Darinaparsin: First Approval
James E. Frampton
Drugs (2022) Vol. 82, Iss. 16, pp. 1603-1609
Closed Access | Times Cited: 13
Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibition
Josh T. Coats, Sudhir Tauro, Calum Sutherland
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging Directions
Robert Stuver, Steven M. Horwitz, Zachary D. Epstein‐Peterson
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 8, pp. 948-964
Closed Access | Times Cited: 4
A novel prognostic nomogram based on imaging and molecular parameters for newly diagnosed extranodal natural killer/T-cell lymphoma patients
Dezhi Huang, Li Fu, Shijia Lin, et al.
Haematologica (2024)
Open Access | Times Cited: 1
Current Treatment of Peripheral T-cell Lymphoma
Steven M. Horwitz, Bertrand Coiffier, Eric D. Hsi, et al.
ONCOLOGY (2022), Iss. 3605
Open Access | Times Cited: 7
Cancer-Related Fatigue Outcome Measures in Integrative Oncology: Evidence for Practice and Research Recommendations
Danielle Gentile, Dori Beeler, Xin Shelley Wang, et al.
ONCOLOGY (2022), Iss. 3605
Open Access | Times Cited: 7
Leukocytoclastic Vasculitis Induced by Immune Checkpoint Inhibition in a Patient With Advanced Renal Cell Carcinoma
Lisa K. Sprod, Robert Stuver, Zachary D. Epstein‐Peterson, et al.
ONCOLOGY (2022), Iss. 3605
Open Access | Times Cited: 6
Cutaneous Intravascular Hematolymphoid Entities: A Review
Emily Hatheway Marshall, Bethany Brumbaugh, Allison Holt, et al.
Diagnostics (2024) Vol. 14, Iss. 7, pp. 679-679
Open Access
Hematopoietic stem cell transplantation to improve prognosis in aggressive monomorphic epitheliotropic intestinal T-cell lymphoma
Gi June Min, Yoon‐Sang Oh, Young‐Woo Jeon, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
TO MARKET, TO MARKET–2022: SMALL MOLECULES
Erika Araujo, Ian M. Bell, Alexander J. Burckle, et al.
Medicinal chemistry reviews (2023), pp. 595-710
Closed Access | Times Cited: 1
Moving towards biologically informed treatment strategies for T-cell lymphomas
Robert Stuver, Natasha Lewis, Ahmet Doğan, et al.
International Journal of Hematology (2022) Vol. 117, Iss. 4, pp. 492-503
Open Access | Times Cited: 1
Peripheral T-Cell Lymphoma, Not Otherwise Specified – a case report and short literature review
Rafael Henriques de Figueiredo, Beatriz Simão Parreira, Pedro Amoroso Canão, et al.
Archive of Clinical Cases (2022) Vol. 9, Iss. 4, pp. 140-144
Open Access | Times Cited: 1
First-Line Therapy for Nodal T-cell Non-Hodgkin Lymphomas: an Unmet Need in Hematology
Vibor Milunović, Inga Mandac Rogulj, Martina Bogeljić Patekar, et al.
Current Oncology Reports (2023) Vol. 25, Iss. 7, pp. 813-824
Closed Access
Deciding Which Cancer-Related Fatigue Assessment Tool to Use Just Got Much Easier
Lisa K. Sprod, Robert Stuver, Zachary D. Epstein‐Peterson, et al.
ONCOLOGY (2022), Iss. 3605
Open Access
Making Progress in PTCL: Significant Unmet Needs
Lisa K. Sprod, Robert Stuver, Zachary D. Epstein‐Peterson, et al.
ONCOLOGY (2022), Iss. 3605
Open Access
Facial oedema and destructive lesion of the hard palate
Edwin Uriel Suárez, A. R. López-García
BMJ (2022), pp. e071929-e071929
Closed Access
Page 1

Scroll to top